The last several weeks have been busy for SourceOne Healthcare Technologies. The company, which was formed in mid-January through the merger of imaging supply distributors Diagnostic Imaging and Healthcare Products, capped a deal with the military for 50
The last several weeks have been busy for SourceOne Healthcare Technologies. The company, which was formed in mid-January through the merger of imaging supply distributors Diagnostic Imaging and Healthcare Products, capped a deal with the military for 50 CR units, entered into two major alliances, and established a new headquarters. It announced Feb. 12 a $5 million contract with the Department of Defense to purchase more than 50 radiological systems manufactured by Orex Computerized Radiography. The Orex PcCR 1417 products include laser scanners and erasable phosphor plates. They will be positioned for use in battlefield situations.
On Feb. 4, SourceOne announced a three-year agreement with the group purchasing organization AmeriNet for equipment and supplies. The deal began Jan. 1 and could be worth $65 million annually, providing film, barium, service, and chemistry to some of AmeriNet's14,000-plus members.
On Jan. 30, the company announced a similar agreement, valued at up to $40 million annually, with MedAssets HSCA. MedAssets' members include more than 2200 acute care facilities and 9000 clinics.
The company also has new digs in Mentor, OH. The development package negotiated by Mentor city officials includes an annual grant, good for 10 years, based on the amount of payroll tax that SourceOne generates. The 170 employees will move to their new 42,000-square-foot structure in May. The SourceOne staff is expected to grow to 300 employees by year's end.
Study: AI Bolsters Sensitivity for Pneumothorax on CXR and Significantly Reduces Reporting Time
October 30th 2024For clinically actionable pneumothorax, an artificial intelligence algorithm demonstrated a 93 percent AUC and a 96 percent specificity rate in a study involving chest X-rays from over 27,000 adults.
AI Segmentation, Intraprostatic Tumor Volume and Metastases: What a New mpMRI Study Reveals
October 29th 2024For patients who received radiotherapy for localized prostate cancer, total intraprostatic tumor volume derived from AI segmentation had a 10 percent higher AUC for predicting seven-year metastases in comparison to a risk model from the National Comprehensive Cancer Network (NCCN).